West Pharmaceutical Services, Inc. (WST) Stock

Healthcare · Medical Instruments & Supplies · Member of S&P 500

West Pharmaceutical Services, Inc. (WST) closed at USD 374.65 on 2026-10-14, a change of +32.6 % over the past year, with a market capitalization of USD 26.96B.

West Pharmaceutical Services, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

West Pharmaceutical Services, Inc. key figures

Previous close

USD 374.65 (2026-10-14)

1-year change

+32.6 %

Market cap

USD 26.96B

Enterprise value

USD 26.84B

P/E ratio (trailing)

49.04

P/E ratio (forward)

38.37

EPS (trailing)

7.81

EPS (forward)

9.98

PEG ratio

2.92

Price to book

9.02

Revenue growth

13.8 %

Earnings growth

18.1 %

Dividend per share (trailing)

0.87

Short ratio

3.47

Employees

10,800

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for West Pharmaceutical Services, Inc. and compare it with other stocks.